FDA approves ATI-1501 for Metronidazole Oral Suspension 500mg/5mL and its brand name LIKMEZ™ Appili received an additional funding commitment from the U.S. Air Force Academy for ATI-1701, bringing the total program funding awarded to US$14 million Appi
PHILADELPHIA--(BUSINESS WIRE)--Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, today announced two poster presentations at the 2023 Society for NeuroOncology (SNO) 28th Annual Meeting in Va
PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics today announced an oral presentation highlighting updated Phase 1/2a clinical data for plixorafenib (FORE8394; PLX8394), the company’s novel, investigational, small-molecule, next-generation, orally av
ROOT, Switzerland--(BUSINESS WIRE)--$NVCR--Novocure (NASDAQ: NVCR) today announced that research on Tumor Treating Fields (TTFields) therapy, including new data from the phase 2 2-THE-TOP trial and real-world evidence from patients diagnosed with glioblas
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic
Presented positive initial data from ongoing Phase 1 MYTHIC clinical trial evaluating lunresertib alone and in combination with camonsertib, including an overall RECIST response rate of 50% in patients with heavily pre-treated gynecological tumors Repare
- Study delivers data required for Phase II trial, on track to initiate next quarter - Confirms linear, dose-proportional pharmacokinetics - Complements strong safety data already reportedTORONTO--(BUSINESS WIRE)--$ATBPF--Antibe Therapeutics Inc. (TSX: A
WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical company utilizing structural biology and a proprietary computational chemistry platform to develop a robust pipeline of novel medicines in immunology, infl
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International (“AGI”) announced that its Nobleford, Alberta manufacturing facility has achieved a significant safety milestone with an impressive three years of no lost time incidents. A lost time inciden
NEW YORK--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products
Dr. Waylon Hunt took an unusual path to co-founding and leading a lab-based business, Intrinsic Analytics.
With a burgeoning scientific portfolio showing a unique ability to boost Akkermansia and Bifidobacteria levels, new products launching before the end of 2023, and international regulatory approvals, Solnul resistant starch “is primed to further penetrate
ElevateIP is a program funded by the Government of Canada aimed at equipping and supporting Canadian start-ups with the tools and knowledge to understand, strategize, protect, manage and leverage their intellectual property (IP)
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.